-
Sector Analysis
NewCloud Computing Market Trends and Analysis by Infrastructure, Product/Service, Vertical, Enterprise Size Band and Segment Forecast to 2027
Accessing the in-depth insights from the ‘Cloud Computing’ report can help: Understand the current and future state of the market, allowing businesses to make informed decisions about market entry, product development, and investments. Identify competitors' capabilities to stay ahead in the market. Identify segments and get an understanding of various stakeholders across different stages of the entire value chain. Anticipate changes in demand and adjust the business development strategies. Identify potential regions and countries for growth opportunities. How is our ‘Cloud Computing’ report different from...
-
Sector Analysis
HER2 Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
HER2 tests Market Report Overview The HER2 tests market size was valued at $123.6 million in 2023. The HER2 tests market will grow at a CAGR of more than 1% from 2023 to 2033. HER2 Testing includes extracting a sample of tumor tissue in a procedure called biopsy, which may be either fine-needle aspiration biopsy, core needle or surgical biopsy. HER2 status can also be determined by next-generation sequencing and array comparative genomic hybridization (aCGH). HER2 tests Market Outlook 2023-2033...
-
Sector Analysis
United States (US) Enterprise ICT Market Analysis and Future Outlook by Segments (Hardware, Software and IT Services)
US Enterprise ICT Market Overview The US enterprise ICT market size was pegged at $1,230.3 billion in 2022 and is expected to grow at a CAGR of more than 8% during 2022-2027 to $1,838.3 billion in 2027. The growth of ICT services in the US is being driven by the increasing digitization of the economy, the rise of emerging technologies, the growing importance of data, and the need for flexibility and agility. ICT services are creating jobs, boosting productivity, and...
-
Sector Analysis
EGFR Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
EGFR Tests Market Report Overview The EGFR tests market size was $17.4 million in 2023 and it will grow at a CAGR of less than 1% during 2023-2033. Epidermal growth factor receptor gene (EGFR) tests are carried out to detect mutations within this receptor gene in non-small cell lung cancer tumor cells. The outcome of may determine if EGFR-targeted tyrosine kinase inhibitors such as gefitinib and erlotinib may be beneficial for treating non-small cell lung cancer (NSCLC). EGFR Tests Market...
-
Sector Analysis
BCR-ABL Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
BCR-ABL Tests Market Overview The BCR-ABL Tests market size was valued at $23.5 million in 2023. The market is expected to grow at a CAGR of more than 5% during 2023-2033. Breakpoint Cluster Region - Tyrosine-Protein Kinase ABL1 fusion gene (BCR-ABL) tests are carried out to detect fusion gene mutations in patient tissue samples. The outcome may guide therapies to treat various cancers including chronic myeloid leukemia (CML), acute lymphoblastic leukemia (ALL), and acute myelogenous leukemia (AML). BCR-ABL Tests Market...
-
Sector Analysis
BRCA Tests Market Size by Segments, Share, Regulatory, Reimbursement and Forecast to 2033
BRCA Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033 is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. The model discusses in detail the impact of COVID-19 on BRCA tests market for the year 2020 and beyond. The BRCA Tests includes Sanger sequencing Tests, Multiplex Ligation-dependent Probe Amplification (MLPA) Tests, Other BRCA Tests such as array comparative genomic hybridization (aCGH), and also nucleic acid amplification tests (NAATs) and MassArray. It is difficult...
-
Sector Analysis
Helicobacter Pylori Tests Market Size by Segments, Share, Regulatory, Reimbursement and Forecast to 2033
Helicobacter Pylori Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033 is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. The model discusses in detail the impact of COVID-19 on Helicobacter Pylori Tests market for the year 2020 and beyond. The Helicobacter Pylori Tests include Helicobacter pylori Breath Test, Helicobacter pylori Feces Test, Helicobacter pylori Serology EIA Test, Helicobacter pylori Rapid Urease Test, Helicobacter pylori Immunohistochemical Test and Helicobacter pylori(POC) Tests. Peptic Ulcer...
-
Product Insights
Lyme Disease – Drugs In Development, 2023
Global Markets Direct’s, ‘Lyme Disease - Drugs In Development, 2023’, provides an overview of the Lyme Disease pipeline landscape. The report provides comprehensive information on the therapeutics under development for Lyme Disease, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Sector Analysis
ALK Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
ALK Tests Market Report Overview The ALK Tests market size was valued at $27.3 million in 2023. The market is expected to grow at a CAGR of more than 2% during 2023-2033. Anaplastic Lymphoma Receptor Tyrosine Kinase (ALK) gene tests are carried out to detect gene rearrangements within non-small cell lung cancer tumor cells, the outcome of which may guide therapies to treat non-small cell lung cancer (NSCLC). ALK Tests Market Outlook 2023-2023 ($ Million) Buy The Full Report for...
-
Sector Analysis
Prenatal Screening Market Size by Segments, Share, Regulatory, Reimbursement and Forecast to 2033
Prenatal Screening Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033 is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. The model discusses in detail the impact of COVID-19 on Prenatal Screening market for the year 2020 and beyond. In most countries, maternal serum screening and ultrasound remain standard-of-care for screening of pregnant women for chromosome aneuploidies and other birth defects. If these tests are positive, then prenatal diagnosis is typically performed via either...